Key facts
- Notable investors include Cherubic Ventures, LINK-J.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for TherapiAI
- ·The full record, as it builds
Funding rounds
No funding rounds for TherapiAI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About TherapiAI
Developer of artificial intelligence-driven cell culture monitoring and regulatory compliance platforms designed for enhancing CDMO process efficiency and accelerating global pharmaceutical innovation. The company offers morphology analysis, culture yield prediction, vitality tracking, process parameter optimization, and impurity detection, thereby ensuring regulatory alignment and scaling intelligent bioprocessing across global markets.
- Sector
- Information Technology
- HQ
- Taipei, Taiwan
- Founded
- 2018
- Website
- therapiai.bio/
- Ownership
- Privately Held (backing)
TherapiAI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in TherapiAI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on TherapiAI in its N-PORT filings yet. We sweep new filings monthly.